Inactive Instrument

News diaDexus, Inc. OTC Bulletin Board

Stocks

DDXS

US25245P1066

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- ^USD	-

21-09-17	Diadexus, Inc. Went Out of Business	CI
18-06-08	Motion for Asset Sale Approved for Diadexus, Inc.	CI

All News

Mentions Relevance

21-09-17	Diadexus, Inc. Went Out of Business	CI
18-06-08	Motion for Asset Sale Approved for Diadexus, Inc.	CI
18-05-09	Motion for Asset Sale Filed by Diadexus, Inc.	CI
16-07-31	Diazyme Laboratories, Inc. completed the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
16-07-29	Motion for Asset Sale Approved for Diadexus, Inc.	CI
16-07-28	General Atomics Corp. entered into purchase agreement to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $4.8 million.	CI
16-07-19	Cleveland HeartLab, Inc. cancelled the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	CI
16-07-07	Motion for Asset Sale Filed by Diadexus, Inc.	CI
16-07-06	Cleveland HeartLab, Inc. agreed to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $7 million.	CI
16-06-13	Diadexus, Inc. Filed for Bankruptcy	CI
16-06-10	Diadexus, Inc. Announces Resignation of Leone Patterson as Chief Financial Office	CI
16-05-23	Diadexus, Sonic Healthcare USA Sign National Agreement for PLAC Activity Test	CI
16-04-29	Diadexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016	CI
16-04-18	Diadexus, Inc. Provides Revenue Guidance for the First Quarter of 2016	CI
16-04-18	Diadexus, Inc. Announces Preliminary Revenue Results for the First Quarter Ended March 31, 2016	CI
16-03-29	Diadexus, Inc. Announces Unaudited Financial Results for the Fourth Quarter and Full Year Ended December 31, 2015	CI
16-03-28	Diadexus, Inc. Auditor Raises 'Going Concern' Doubt	CI
16-03-18	Diadexus, Inc. Announces Resignation of Dr. Emilia Zychlinksy as Executive Vice President and Chief Technical Officer, Effective as of April 1, 2016	CI
15-11-10	Diadexus, Inc. Presents New Plac(r) Activity Data from the Regards Study at 2015 American Heart Association Scientific Sessions	CI
15-10-26	Diadexus, Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015	CI
15-10-13	Diadexus, Inc. Names Jonathan Ruais as Vice President of Marketing	CI
15-09-08	DiaDexus Signs License Agreement with OriGene Technologies and Wuxi OriGene Biotechnology	CI
15-09-03	Diadexus, Inc. announced that it has received $1 million in funding from OriGene Technologies, Inc..	CI
15-08-13	Diadexus, Inc., Q2 2015 Earnings Call, Aug 13, 2015
15-08-13	Diadexus, Inc. Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended June 30, 2015; Rescinds Revenue Guidance for 2015	CI